JP2013516991A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516991A5 JP2013516991A5 JP2012549089A JP2012549089A JP2013516991A5 JP 2013516991 A5 JP2013516991 A5 JP 2013516991A5 JP 2012549089 A JP2012549089 A JP 2012549089A JP 2012549089 A JP2012549089 A JP 2012549089A JP 2013516991 A5 JP2013516991 A5 JP 2013516991A5
- Authority
- JP
- Japan
- Prior art keywords
- apyrase
- soluble
- nucleic acid
- acid construct
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29469510P | 2010-01-13 | 2010-01-13 | |
| US61/294,695 | 2010-01-13 | ||
| PCT/US2011/021187 WO2011088244A1 (en) | 2010-01-13 | 2011-01-13 | Therapeutic apyrase constructs, apyrase agents, and production methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013516991A JP2013516991A (ja) | 2013-05-16 |
| JP2013516991A5 true JP2013516991A5 (https=) | 2014-02-27 |
| JP5913130B2 JP5913130B2 (ja) | 2016-04-27 |
Family
ID=44304650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012549089A Active JP5913130B2 (ja) | 2010-01-13 | 2011-01-13 | 治療用アピラ−ゼ構築物、アピラ−ゼ作用物質、及び製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8771683B2 (https=) |
| EP (1) | EP2523971B1 (https=) |
| JP (1) | JP5913130B2 (https=) |
| KR (1) | KR20130009744A (https=) |
| AU (1) | AU2011205248A1 (https=) |
| BR (1) | BR112012017243A2 (https=) |
| CA (1) | CA2787016C (https=) |
| IL (1) | IL220882A0 (https=) |
| RU (1) | RU2012134366A (https=) |
| WO (1) | WO2011088244A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2941254B1 (en) * | 2014-03-12 | 2017-01-11 | Shiseido Company, Ltd. | Agent for sedating response to external stimulation in skin and method for sedating that response technical field |
| CN105018442A (zh) * | 2014-04-23 | 2015-11-04 | Apt治疗公司 | 改进的en-腺苷三磷酸双磷酸酶 |
| UY38299A (es) | 2018-07-18 | 2020-02-28 | Novartis Ag | Apirasas solubilizadas, métodos y usos |
| TW202146042A (zh) * | 2020-03-06 | 2021-12-16 | 瑞典商阿斯特捷利康公司 | 用於治療動脈和靜脈血栓形成的協同且靶向的組成物 |
| CA3098818A1 (en) | 2020-08-19 | 2022-02-19 | Astrazeneca Ab | Combination treatment |
| JP7547996B2 (ja) * | 2020-12-22 | 2024-09-10 | トヨタ自動車株式会社 | コイルの製造方法 |
| WO2024089196A1 (en) | 2022-10-28 | 2024-05-02 | Astrazeneca Ab | Recombinant apyrase protein for use in the treatment of an ischemic event at a dose of 40-240 mg |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322678A (en) | 1988-02-17 | 1994-06-21 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
| KR100545945B1 (ko) * | 2000-07-03 | 2006-01-25 | 갈라 디자인, 인크. | 발현 벡터 |
| US7247300B1 (en) | 2002-11-07 | 2007-07-24 | Apt Therapeutics, Inc. | Therapeutic use of soluble CD39L3 |
| EP1733045A4 (en) | 2004-02-27 | 2008-08-13 | Apt Therapeutics Inc | DESIGN AND THERAPEUTIC USE OF ADPASE-ENHANCED APYRASES |
| TWI384069B (zh) * | 2004-08-27 | 2013-02-01 | Pfizer Ireland Pharmaceuticals | 多胜肽之製法 |
-
2011
- 2011-01-13 KR KR1020127021160A patent/KR20130009744A/ko not_active Withdrawn
- 2011-01-13 EP EP11733394.8A patent/EP2523971B1/en active Active
- 2011-01-13 AU AU2011205248A patent/AU2011205248A1/en not_active Abandoned
- 2011-01-13 US US13/522,311 patent/US8771683B2/en active Active
- 2011-01-13 CA CA2787016A patent/CA2787016C/en active Active
- 2011-01-13 BR BR112012017243A patent/BR112012017243A2/pt not_active Application Discontinuation
- 2011-01-13 JP JP2012549089A patent/JP5913130B2/ja active Active
- 2011-01-13 RU RU2012134366/10A patent/RU2012134366A/ru not_active Application Discontinuation
- 2011-01-13 WO PCT/US2011/021187 patent/WO2011088244A1/en not_active Ceased
-
2012
- 2012-07-11 IL IL220882A patent/IL220882A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013516991A5 (https=) | ||
| JP2013027391A5 (https=) | ||
| JP2012519489A5 (https=) | ||
| JP2010273685A5 (https=) | ||
| JP2011224002A5 (https=) | ||
| JP2010166916A5 (https=) | ||
| JP2015212284A5 (https=) | ||
| JP2009519013A5 (https=) | ||
| JP2017536098A5 (https=) | ||
| JP2009148257A5 (https=) | ||
| JP2016526013A5 (https=) | ||
| RU2012134366A (ru) | Терапевтические конструкции апиразы, средства на основе апиразы и способы получения | |
| JP2016513478A5 (https=) | ||
| JP2014511692A5 (https=) | ||
| JP2015524413A5 (https=) | ||
| CN103214563A (zh) | 一种性能改进的重组金黄色葡萄球菌蛋白a亲和配基及其构建方法 | |
| JP2011521661A5 (https=) | ||
| JP2013531491A5 (https=) | ||
| JP2010207199A5 (https=) | ||
| JP2013531967A5 (https=) | ||
| CN102241759B (zh) | 一种抑菌性铁蛋白及其制备和应用 | |
| JP2013512675A5 (https=) | ||
| CA2795142A1 (en) | Fusion protein | |
| IN2012DN01315A (https=) | ||
| JP2013055917A5 (https=) |